Skip to content

Fanconi Anemia Complementation Group W C4521564

Published: July 22, 2026Updated: August 20, 2026

A subtype of Fanconi anemia affecting DNA repair. It can cause bone marrow failure, physical anomalies, and higher cancer risk. Management involves supportive therapy and potential stem cell transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D61.03
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Medication Comparisons

Compare medications used to treat Fanconi Anemia Complementation Group W C4521564. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy